| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Daniele Focosi | Q51451209 |
| P2093 | author name string | Giovanni Amabile | |
| P2860 | cites work | Production of embryonic and fetal-like red blood cells from human induced pluripotent stem cells | Q21560913 |
| Induced pluripotent stem cells in hematology: current and future applications | Q27016090 | ||
| Large-scale production of megakaryocytes from human pluripotent stem cells by chemically defined forward programming | Q27320898 | ||
| Two differential flows in a bioreactor promoted platelet generation from human pluripotent stem cell-derived megakaryocytes | Q86657049 | ||
| Induced pluripotent stem cell lines derived from human somatic cells | Q27860597 | ||
| Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors | Q27860937 | ||
| Induction of pluripotent stem cells from adult human fibroblasts by defined factors | Q27860967 | ||
| Transient activation of c-MYC expression is critical for efficient platelet generation from human induced pluripotent stem cells | Q33392928 | ||
| Induced pluripotent stem cell-derived human platelets: one step closer to the clinic | Q33393364 | ||
| Generation of functional platelets from canine induced pluripotent stem cells | Q33405886 | ||
| Expandable megakaryocyte cell lines enable clinically applicable generation of platelets from human induced pluripotent stem cells | Q33413336 | ||
| Generation of HLA-universal iPSCs-derived megakaryocytes and platelets for survival under refractoriness conditions | Q33432719 | ||
| Direct Conversion of Fibroblasts to Megakaryocyte Progenitors | Q33435963 | ||
| Activation of KLF1 Enhances the Differentiation and Maturation of Red Blood Cells from Human Pluripotent Stem Cells. | Q33578349 | ||
| Enhancement of β-Globin Gene Expression in Thalassemic IVS2-654 Induced Pluripotent Stem Cell-Derived Erythroid Cells by Modified U7 snRNA. | Q33722582 | ||
| Transcriptional silencing of {gamma}-globin by BCL11A involves long-range interactions and cooperation with SOX6. | Q33788501 | ||
| Qualitative and quantitative comparison of the proteome of erythroid cells differentiated from human iPSCs and adult erythroid cells by multiplex TMT labelling and nanoLC-MS/MS | Q33895201 | ||
| Reprogramming induced pluripotent stem cells in the absence of c-Myc for differentiation into hepatocyte-like cells | Q33928366 | ||
| Direct induction of haematoendothelial programs in human pluripotent stem cells by transcriptional regulators. | Q33935685 | ||
| Biologic properties and enucleation of red blood cells from human embryonic stem cells | Q34013422 | ||
| Functional genomics, proteomics, and regulatory DNA analysis in isogenic settings using zinc finger nuclease-driven transgenesis into a safe harbor locus in the human genome | Q34018343 | ||
| In vivo generation of transplantable human hematopoietic cells from induced pluripotent stem cells. | Q34034653 | ||
| Generation of genome integration-free induced pluripotent stem cells from fibroblasts of C57BL/6 mice without c-Myc transduction | Q34074419 | ||
| Inactivation of human white blood cells in platelet products after pathogen reduction technology treatment in comparison to gamma irradiation | Q34154813 | ||
| Red blood cell generation from human induced pluripotent stem cells: perspectives for transfusion medicine. | Q34166525 | ||
| Platelet bioreactor-on-a-chip | Q34209300 | ||
| Human induced pluripotent stem cells can reach complete terminal maturation: in vivo and in vitro evidence in the erythropoietic differentiation model. | Q34284032 | ||
| Chemically defined conditions for human iPSC derivation and culture | Q34890309 | ||
| Platelet function tests: a comparative review | Q35121464 | ||
| Generation of red blood cells from human induced pluripotent stem cells | Q35179358 | ||
| Dissecting the role of aberrant DNA methylation in human leukaemia | Q35645500 | ||
| The multifunctional role of EKLF/KLF1 during erythropoiesis | Q35797596 | ||
| Leukosialin (CD43) defines hematopoietic progenitors in human embryonic stem cell differentiation cultures | Q35849083 | ||
| Distinct gene expression program dynamics during erythropoiesis from human induced pluripotent stem cells compared with adult and cord blood progenitors | Q36171095 | ||
| Integrity of Induced Pluripotent Stem Cell (iPSC) Derived Megakaryocytes as Assessed by Genetic and Transcriptomic Analysis | Q36255345 | ||
| A Comprehensive, Ethnically Diverse Library of Sickle Cell Disease-Specific Induced Pluripotent Stem Cells | Q36256816 | ||
| Induction of functional platelets from mouse and human fibroblasts by p45NF-E2/Maf | Q36370865 | ||
| Targeted Application of Human Genetic Variation Can Improve Red Blood Cell Production from Stem Cells | Q36450196 | ||
| Poly(ADP-ribose) polymerase 1 regulates nuclear reprogramming and promotes iPSC generation without c-Myc | Q36547699 | ||
| Effect of Induced Pluripotent Stem Cell Technology in Blood Banking | Q36728573 | ||
| Improved hematopoietic differentiation of human pluripotent stem cells via estrogen receptor signaling pathway | Q37221343 | ||
| High-Efficiency Serum-Free Feeder-Free Erythroid Differentiation of Human Pluripotent Stem Cells Using Small Molecules | Q37272414 | ||
| Leukoreduction and ultraviolet treatment reduce both the magnitude and the duration of the HLA antibody response | Q37303143 | ||
| Induced pluripotent stem cells: current progress and potential for regenerative medicine | Q37375444 | ||
| Early-stage epigenetic modification during somatic cell reprogramming by Parp1 and Tet2 | Q37524401 | ||
| Technological overview of iPS induction from human adult somatic cells | Q38074176 | ||
| A molecular roadmap of definitive erythropoiesis from human induced pluripotent stem cells | Q38722673 | ||
| Epigenetic variation between human induced pluripotent stem cell lines is an indicator of differentiation capacity | Q38754538 | ||
| Derivation of Transgene-Free Induced Pluripotent Stem Cells from a Single Drop of Blood | Q38830555 | ||
| Superior Red Blood Cell Generation from Human Pluripotent Stem Cells Through a Novel Microcarrier-Based Embryoid Body Platform. | Q38843844 | ||
| Application of Induced Pluripotent Stem Cell Technology to the Study of Hematological Diseases | Q39173212 | ||
| Efficient Generation of β-Globin-Expressing Erythroid Cells Using Stromal Cell-Derived Induced Pluripotent Stem Cells from Patients with Sickle Cell Disease. | Q39292498 | ||
| A common bipotent progenitor generates the erythroid and megakaryocyte lineages in embryonic stem cell-derived primitive hematopoiesis. | Q39845785 | ||
| The aging population poses a global challenge for blood services | Q39929409 | ||
| In vitro clinical-grade generation of red blood cells from human umbilical cord blood CD34+ cells | Q40063888 | ||
| Platelet production from induced pluripotent stem cells | Q40115861 | ||
| Drug discovery for Diamond-Blackfan anemia using reprogrammed hematopoietic progenitors | Q40343635 | ||
| Emergence of CD43-Expressing Hematopoietic Progenitors from Human Induced Pluripotent Stem Cells | Q41813455 | ||
| Selective Inhibition of ADAM17 Efficiently Mediates Glycoprotein Ibα Retention During Ex Vivo Generation of Human Induced Pluripotent Stem Cell-Derived Platelets | Q42247805 | ||
| Scalable generation of universal platelets from human induced pluripotent stem cells. | Q43010381 | ||
| HLA-universal platelet transfusions prevent platelet refractoriness in a mouse model | Q43694633 | ||
| The New Federalism: State Policies Regarding Embryonic Stem Cell Research. | Q45932164 | ||
| Treatment of whole blood with riboflavin plus ultraviolet light, an alternative to gamma irradiation in the prevention of transfusion-associated graft-versus-host disease? | Q46505820 | ||
| Treatment with riboflavin and ultraviolet light prevents alloimmunization to platelet transfusions and cardiac transplants | Q46902802 | ||
| Induced Pluripotent Stem Cell-Derived Megakaryocytes and Platelets for Disease Modeling and Future Clinical Applications | Q47913269 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P577 | publication date | 2017-12-27 | |
| P1433 | published in | Cells | Q27724621 |
| P1476 | title | Induced Pluripotent Stem Cell-Derived Red Blood Cells and Platelet Concentrates: From Bench to Bedside | |
| P478 | volume | 7 |
| Q58751503 | A β1-tubulin-based megakaryocyte maturation reporter system identifies novel drugs that promote platelet production |
| Q90603771 | Enhanced Ex Vivo Generation of Erythroid Cells from Human Induced Pluripotent Stem Cells in a Simplified Cell Culture System with Low Cytokine Support |
| Q58733966 | Inducible pluripotent stem cell-derived mesenchymal stem cell therapy effectively protected kidney from acute ischemia-reperfusion injury |
| Q65002709 | Recent Updates on Induced Pluripotent Stem Cells in Hematological Disorders. |
| Q64103339 | Spare Parts from Discarded Materials: Fetal Annexes in Regenerative Medicine |
| Q90533221 | The Shape Shifting Story of Reticulocyte Maturation |
Search more.